- Home
- ICLR vs POET Comparison
ICLR vs POET Comparison
Compare ICLR & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- POET
- Stock Information
- Founded
- ICLR 1990
- POET 1972
- Country
- ICLR Ireland
- POET Canada
- Employees
- ICLR N/A
- POET N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- POET Semiconductors
- Sector
- ICLR Health Care
- POET Technology
- Exchange
- ICLR Nasdaq
- POET Nasdaq
- Market Cap
- ICLR 11.5B
- POET N/A
- IPO Year
- ICLR 1998
- POET N/A
- Fundamental
- Price
- ICLR $133.96
- POET $4.48
- Analyst Decision
- ICLR Buy
- POET Strong Buy
- Analyst Count
- ICLR 12
- POET 2
- Target Price
- ICLR $206.64
- POET $6.25
- AVG Volume (30 Days)
- ICLR 2.1M
- POET 545.8K
- Earning Date
- ICLR 04-30-2025
- POET 05-14-2025
- Dividend Yield
- ICLR N/A
- POET N/A
- EPS Growth
- ICLR 11.53
- POET N/A
- EPS
- ICLR 9.19
- POET N/A
- Revenue
- ICLR $8,192,621,999.00
- POET $41,427.00
- Revenue This Year
- ICLR $1.63
- POET $9,379.33
- Revenue Next Year
- ICLR $4.82
- POET $684.42
- P/E Ratio
- ICLR $15.07
- POET N/A
- Revenue Growth
- ICLR N/A
- POET N/A
- 52 Week Low
- ICLR $133.28
- POET $1.60
- 52 Week High
- ICLR $347.72
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- ICLR 33.96
- POET 61.99
- Support Level
- ICLR $135.00
- POET $4.10
- Resistance Level
- ICLR $141.96
- POET $4.50
- Average True Range (ATR)
- ICLR 6.69
- POET 0.23
- MACD
- ICLR 0.43
- POET 0.05
- Stochastic Oscillator
- ICLR 3.63
- POET 82.65
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.